What does CUSIP 00650F109 represent in this 13F holders report?

CUSIP 00650F109 is the security identifier for ADPT - Adaptive Biotechnologies Corp - Common Stock used to aggregate holder disclosures.

How many institutions held ADPT - Adaptive Biotechnologies Corp - Common Stock in Q2 2022?

196 institutional investors reported ADPT - Adaptive Biotechnologies Corp - Common Stock for Q2 2022. Use the holders table for investor-level position and value details.

Adaptive Biotechnologies Corp - Common Stock (ADPT)

CUSIP: 00650F109

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock
Shares outstanding: 151,803,139
Total 13F shares: 134,391,278
Share change: +9,376,678
Total reported value: $1,083,708,756
Put/Call ratio: 36%
Price per share: $8.09
Number of holders: 196
Value change: +$49,040,887
Number of buys: 112
Number of sells: 88

Quarterly Holders Quick Answers

What is CUSIP 00650F109?
CUSIP 00650F109 identifies ADPT - Adaptive Biotechnologies Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 00650F109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ADPT - Adaptive Biotechnologies Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VIKING GLOBAL INVESTORS LP	13F	Company	20%	29,993,708	$416,313,000	—	31 Mar 2022	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	8.2%	12,416,367	$172,339,000	—	31 Mar 2022	13F
Matrix Capital Management Company, LP	13F	Company	7.6%	11,572,590	$160,628,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	7.3%	11,090,834	$153,941,000	—	31 Mar 2022	13F
ARK Investment Management LLC	13F	Company	5.1%	7,709,666	$107,010,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	3.9%	5,966,501	$82,814,000	—	31 Mar 2022	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	2.7%	4,132,060	$57,353,000	—	31 Mar 2022	13F
Amova Asset Management Americas, Inc.	13F	Company	2.7%	4,140,778	$56,522,000	—	31 Mar 2022	13F
Bellevue Group AG	13F	Company	2.1%	3,145,293	$43,657,000	—	31 Mar 2022	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	1.9%	2,877,843	$39,945,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	1.2%	1,874,471	$26,018,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.93%	1,414,415	$19,632,000	—	31 Mar 2022	13F
Neuberger Berman Group LLC	13F	Company	0.84%	1,268,073	$17,601,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.77%	1,176,102	$16,325,000	—	31 Mar 2022	13F
NORGES BANK	13F	Company	0.7%	1,065,469	$14,788,710	—	31 Mar 2022	13F
Eagle Health Investments LP	13F	Company	0.67%	1,014,860	$14,086,000	—	31 Mar 2022	13F
Casdin Capital, LLC	13F	Company	0.66%	1,000,000	$13,880,000	—	31 Mar 2022	13F
Senator Investment Group LP	13F	Company	0.66%	1,000,000	$13,880,000	—	31 Mar 2022	13F
MARSHALL WACE, LLP	13F	Company	0.61%	925,518	$12,846,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.6%	905,769	$12,572,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.57%	859,768	$11,934,000	—	31 Mar 2022	13F
TimesSquare Capital Management, LLC	13F	Company	0.52%	788,585	$10,946,000	—	31 Mar 2022	13F
Aristotle Atlantic Partners, LLC	13F	Company	0.5%	759,412	$10,541,000	—	31 Mar 2022	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.43%	648,479	$9,000,000	—	31 Mar 2022	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	0.39%	596,873	$8,285,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.39%	589,825	$8,187,000	—	31 Mar 2022	13F
TIGER MANAGEMENT L.L.C.	13F	Company	0.39%	589,311	$8,180,000	—	31 Mar 2022	13F
FEDERATED HERMES, INC.	13F	Company	0.37%	556,199	$7,720,000	—	31 Mar 2022	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.34%	515,891	$7,161,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.33%	507,254	$7,040,000	—	31 Mar 2022	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.31%	465,564	$6,462,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.31%	464,258	$6,443,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.3%	462,924	$6,425,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.3%	455,600	$6,324,000	—	31 Mar 2022	13F
Allianz Asset Management GmbH	13F	Company	0.24%	366,290	$5,084,000	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.22%	341,420	$4,739,000	—	31 Mar 2022	13F
Pier Capital, LLC	13F	Company	0.22%	339,541	$4,713,000	—	31 Mar 2022	13F
Tekla Capital Management LLC	13F	Company	0.22%	337,722	$4,688,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.22%	329,115	$4,569,000	—	31 Mar 2022	13F
PEREGRINE CAPITAL MANAGEMENT LLC	13F	Company	0.21%	318,145	$4,416,000	—	31 Mar 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.2%	309,850	$4,301,000	—	31 Mar 2022	13F
Triatomic Management LP	13F	Company	0.2%	297,048	$4,123,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.21%	324,822	$4,109,000	—	31 Mar 2022	13F
THRIVENT FINANCIAL FOR LUTHERANS	13F	Company	0.19%	292,956	$4,067,000	—	31 Mar 2022	13F
CWM, LLC	13F	Company	0.18%	269,179	$3,736,000	—	31 Mar 2022	13F
Diametric Capital, LP	13F	Company	0.17%	265,000	$3,678,000	—	31 Mar 2022	13F
LAZARD ASSET MANAGEMENT LLC	13F	Company	0.16%	236,870	$3,286,000	—	31 Mar 2022	13F
JANE STREET GROUP, LLC	13F	Company	0.15%	228,889	$3,177,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.14%	216,900	$3,011,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.14%	209,463	$2,908,000	—	31 Mar 2022	13F

Institutional Holders of Adaptive Biotechnologies Corp - Common Stock (ADPT) as of Q2 2022

As of 30 Jun 2022, Adaptive Biotechnologies Corp - Common Stock (ADPT) was held by 196 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 134,391,278 shares. The largest 10 holders included VIKING GLOBAL INVESTORS LP, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Matrix Capital Management Company, LP, BlackRock Inc., ARK Investment Management LLC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., Bellevue Group AG, and Blue Water Life Science Advisors, LP. This page lists 196 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

207

Q2 2022 holders

196

Holder diff

-11

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.